Search research articles
Contact Us
Filters
Showing results (151-160 of 165) with videos related to
Page
of 17
Sort By:
NPJ Precision Oncology
|
April 29, 2021
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival
Vladimir Lazar, Shai Magidi, Nicolas Girard, et al.
Clinical and Translational Medicine
|
May 1, 2021
Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer
Karen Gambaro, Maud Marques, Suzan McNamara, et al.
Therapeutic Advances in Medical Oncology
|
November 3, 2022
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high <i>ACE2</i>-expressing normal lung
Vladimir Lazar, Jacques Raynaud, Shai Magidi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application
Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 8, 2013
Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine
Zuanel Diaz, Adriana Aguilar-Mahecha, Eric R Paquet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application
Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
JCO Precision Oncology
|
September 15, 2022
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies
Vladimir Lazar, Nicolas Girard, Eric Raymond, et al.
NPJ Breast Cancer
|
April 17, 2021
Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer
Lillian M Smyth, Gerald Batist, Funda Meric-Bernstam, et al.
Clinical Lung Cancer
|
May 14, 2024
Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis
Amit A Kulkarni, Cassandra Hennessy, Grace Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2017
A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in <i>PIK3CA</i>-Mutated Breast and Gynecologic Cancers
Udai Banerji, Emma J Dean, J Alejandro Pérez-Fidalgo, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 165) with videos related to
Sort By:
Page
of 17
NPJ Precision Oncology
|
April 29, 2021
Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival
Vladimir Lazar, Shai Magidi, Nicolas Girard, et al.
Clinical and Translational Medicine
|
May 1, 2021
Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer
Karen Gambaro, Maud Marques, Suzan McNamara, et al.
Therapeutic Advances in Medical Oncology
|
November 3, 2022
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high <i>ACE2</i>-expressing normal lung
Vladimir Lazar, Jacques Raynaud, Shai Magidi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application
Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 8, 2013
Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine
Zuanel Diaz, Adriana Aguilar-Mahecha, Eric R Paquet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application
Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
JCO Precision Oncology
|
September 15, 2022
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies
Vladimir Lazar, Nicolas Girard, Eric Raymond, et al.
NPJ Breast Cancer
|
April 17, 2021
Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer
Lillian M Smyth, Gerald Batist, Funda Meric-Bernstam, et al.
Clinical Lung Cancer
|
May 14, 2024
Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis
Amit A Kulkarni, Cassandra Hennessy, Grace Wilson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2017
A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in <i>PIK3CA</i>-Mutated Breast and Gynecologic Cancers
Udai Banerji, Emma J Dean, J Alejandro Pérez-Fidalgo, et al.
Page
of 17